908 Devices (NASDAQ:MASS) Earns "Sell (E+)" Rating from Weiss Ratings

Weiss Ratings reaffirmed their sell (e+) rating on shares of 908 Devices (NASDAQ:MASS - Free Report) in a report released on Saturday morning,Weiss Ratings reports.

Separately, Stephens reaffirmed an "overweight" rating and set a $6.00 price target on shares of 908 Devices in a research report on Wednesday, January 15th. Two analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to MarketBeat, 908 Devices currently has an average rating of "Moderate Buy" and a consensus price target of $5.33.

908 Devices Stock Down 1.0 %

Shares of MASS traded down $0.04 during mid-day trading on Friday, hitting $4.01. 469,822 shares of the company traded hands, compared to its average volume of 938,581. The company has a market capitalization of $141.67 million, a PE ratio of -2.27 and a beta of 0.99. The business has a 50 day moving average of $3.02 and a 200 day moving average of $2.94. 908 Devices has a 1-year low of $1.81 and a 1-year high of $7.56.

Hedge Funds Weigh In On 908 Devices

Institutional investors have recently made changes to their positions in the company. Two Sigma Advisers LP purchased a new stake in 908 Devices during the fourth quarter worth $30,000. Prudential Financial Inc. acquired a new stake in shares of 908 Devices during the 4th quarter valued at about $34,000. Occudo Quantitative Strategies LP purchased a new position in shares of 908 Devices in the 4th quarter valued at about $36,000. Two Sigma Investments LP acquired a new position in 908 Devices in the 4th quarter worth about $42,000. Finally, B. Riley Wealth Advisors Inc. acquired a new stake in 908 Devices in the third quarter valued at approximately $45,000. 88.06% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

About 908 Devices

908 Devices Inc, a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, pharma/biopharma, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and Maverick, an optical in-line analyzer that offers real-time monitoring and control of multiple bioprocess parameters, including glucose, lactate, and total biomass in mammalian cell cultures, as well as provides process fingerprint data to support large-scale efforts in predictive bioprocess modeling.